TherapeuticsMD Names Joel S. Krasnow, M.D. as Chief Scientific Officer
December 04, 2013 at 07:08 AM EST
TherapeuticsMD (NYSE: TXMD ) announced today the appointment of Joel S. Krasnow, M.D., M.B.A., a leading board-certified OB/GYN and reproductive endocrinologist with broad biotech and pharmaceutical experience, as
